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Background: The optimal management of acute cervical spinal cord injury (SCI) associated with preexisting canal
stenosis remains to be established. The objective of this study is to examine whether early surgical decompression
(within 24 hours after admission) would result in greater improvement in motor function compared with delayed
surgery (later than two weeks) in cervical SCI patients presenting with canal stenosis, but without bony injury.
Methods/design: OSCIS is a randomized, controlled, parallel-group, assessor-blinded, multicenter trial. We will
recruit 100 cervical SCI patients who are admitted within 48 hours of injury (aged 20 to 79 years; without fractures
or dislocations; American Spinal Injury Association (ASIA) grade C; preexisting spinal canal stenosis). Patients will be
enrolled from 36 participating hospitals across Japan and randomly allocated in a 1:1 ratio to either early surgical
decompression (within 24 hours after admission) or delayed surgery following at least two weeks of conservative
treatment. The primary outcomes include: 1) the change from baseline to one year in the ASIA motor score; 2) the
total score of the Spinal Cord Independence Measure and 3) the proportion of patients who are able to walk
without human assistance. The secondary outcomes are: 1) the health-related quality of life as measured by the
Medical Outcomes Study Short Form 36 and the EuroQol 5 Dimension; 2) the Neuropathic Pain Symptom Inventory
and 3) the walking status as evaluated with the Walking Index for Spinal Cord Injury II. The analysis will be on an
intention-to-treat basis. The primary analysis will be a comparison of the primary and secondary outcomes one year
after the injury.
Discussion: The results of this study will provide evidence of the potential benefit of early surgical decompression
compared to the current ‘watch and wait’ strategy.
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Acute cervical spinal cord injury (SCI) is one of the most
devastating conditions, and can lead to paralysis, sensory
impairment and bowel, bladder and sexual dysfunction.
In addition, patients frequently suffer from intractable
pain caused by neural damage. Individuals with cervical
canal stenosis are known to develop cervical SCI even
after minor trauma. Cervical canal stenosis may be con-
genital, but often results from degenerative conditions,
such as spondylosis. The SCI patients with canal stenosis
are mostly elderly, and usually present with incomplete
SCI without bone injury, such as spinal fracture or dis-
location. This subgroup of patients has been steadily in-
creasing as the society ages and currently accounts for
over 60% of cervical SCIs in Japan [1].
The clinical outcome of patients with incomplete SCI
has been considered to be favorable, since patients usu-
ally show spontaneous neurologic recovery to some ex-
tent. However, the neurological prognosis varies greatly
among patients; about half of ASIA C patients remain
non-ambulatory six months after the injury [2]. In par-
ticular, the clinical outcomes of elderly patients are often
suboptimal [3,4]. Therefore, a therapeutic option that
leads to a better clinical outcome is urgently needed.
Controversy exists with regard to the efficacy of surgi-
cal decompression in the treatment of cervical SCI with
preexisting canal stenosis [5,6]. The role of surgery re-
main unclear, especially in the absence of instability of
the cervical spine [7], thus resulting in a significant dif-
ference in practice between institutions. A common ap-
proach to treating these patients has been to rule out
acute instability and then observe the patients’ spontan-
eous neurological recovery until they achieve a neuro-
logical plateau, and only then consider the possibility of
surgical decompression, weeks after the initial injury [6].
Our previous retrospective multicenter study showed
that the time from injury to surgery was approximately
two weeks (median 13.5 days) [8].
The main drawback of this ‘watch and wait’ strategy is
that a potential therapeutic window in the acute phase
might be missed. The current concept of the pathophysi-
ology of SCI classifies the spinal damage into two stages:
primary injury and secondary injury [9]. The primary in-
jury results from the mechanical forces delivered to the
spinal cord at the time of the trauma. Secondary injury is
a cascade of pathophysiological events including edema,
ischemia, inflammation and apoptosis following the initial
impact, which develops within minutes to hours following
the trauma. There is a growing body of evidence from pre-
clinical or animal studies that early surgical decompres-
sion alleviates ‘secondary injury’ and thus results in
enhanced neurological and functional recovery [5].
Although numerous studies have been performed to
examine the potential benefit of early surgery, the resultsof these prior clinical studies were mixed, and failed to
provide robust support for the hypothesis that early sur-
gery leads to improved outcomes. One small randomized
trial of 42 patients showed no benefit to early (< 72
hours) decompression [10]. On the other hand, a meta-
analysis of case series showed that early (< 24 hours) de-
compression was associated with better outcomes com-
pared to both delayed (> 24 hours) and conservative
treatment [11]. The results of STASCIS, one of the lar-
gest prospective studies of 313 patients, were also in
favor of early surgery [12]. The authors of that study
reported that early surgery, within 24 hours after injury,
is associated with an improved neurological outcome,
defined as at least a two grade ASIA Impairment Scale
(AIS) improvement at the six-month follow-up examin-
ation. However, the difference in the chance of experien-
cing a one grade AIS improvement between early versus
late surgery was not statistically significant.
With such conflicting information in the literature and
a lack of high-quality evidence, it remains unclear
whether early surgical decompression would result in
better neurological and functional recovery. To address
this issue, we launched the OSCIS study (Optimal treat-
ment for Spinal Cord Injury associated with cervical
canal Stenosis), a randomized, controlled, multicenter
trial, in which we will compare the two strategies: early
surgery within 24 hours after admission and delayed sur-
gery following at least two weeks of conservative
treatment.Methods/design
Trial design
The OSCIS study is a randomized, controlled, parallel-
group, assessor-blinded, multicenter study. Patients will
be randomly allocated to undergo either early surgery or
delayed surgery. The aim of this study is to test the hy-
pothesis that early surgery (within 24 hours after admis-
sion) will lead to greater improvements in the motor
function compared to delayed surgery (later than two
weeks after injury) in patients with acute cervical SCI as-
sociated with canal stenosis. The flowchart shown in
Figure 1 provides a visual description of the study.Participants
Subjects will be recruited from 36 hospitals in Japan.
The list of the participating hospitals with approval from
local ethical boards is available as Additional file 1. We
will screen all patients with acute traumatic cervical
spinal cord injury (at C5 or below) who are admitted to
one of the institutions within 48 hours after the injury.
The diagnosis of cervical spinal cord injury will be made
on the patient’s history, including physical and neuro-
logical examinations, and the results of imaging studies,
Figure 1 Study flowchart.
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(MRI) and computed tomography (CT).
Inclusion criteria
Subjects will be eligible for inclusion if they satisfy the
following inclusion criteria:
 aged 20 to 79 years
 without bone injury (spinal fracture or dislocation)
 American Spinal Injury Association (ASIA)
impairment Grade C
 cervical canal stenosis due to preexisting conditions,
such as spondylosis and ossification of the posterior
longitudinal ligament (OPLL)
The presence of cervical canal stenosis will be con-
firmed by physicians based on the MRI findings obtained
on admission. The presence of OPLL will be determined
by using plain radiographs or CT. The thickness of the
OPLL must be 20% or more of the spinal canal.Exclusion criteria
Subjects will be excluded from enrollment if they meet
any of the following conditions:
 unstable medical status
 unable to undergo surgery within 24 hours after
admission
 impaired consciousness or mental disorder that
precludes neurological examination
 difficulty in obtaining informed consent in Japanese
Randomization
We will adopt the web-based allocation system using the
University Medical Information Network (UMIN), which
is one of the data centers that run as a public institution
in Japan. By entering the information about the patient,
investigators will be able to know the allocation results
immediately.
The allocation table, which was created by stratified
block randomized by the trial statistician, is registered in
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tors involved in this study. We have adopted stratifica-
tion factors as follows:
 the presence of ossification of the posterior
longitudinal ligament (OPLL) (yes/no)
 implementation of high-dose methylprednisolone
treatment according to the NASCIS2 protocol
(yes/no)
 preexisting gait disturbance due to myelopathy
 degree of canal compromise (50% or more/less than
50% canal compromise)
Preexisting gait disturbance due to myelopathy will be
determined by the attending spine surgeon before
randomization, based on thorough patients’ history and
available medical record. Gait disturbance attributable to
other causes (for example, trauma, osteoarthritis, and
paralysis after stroke) will be excluded.
Presence of severe canal compromise (50% or more
canal compromise) will be assessed by the attending spine
surgeon based on mid-sagittal MR images obtained at
admission. For patients presented with OPLL, mid-
sagittal reconstruction CT images or plain radiographs
of the cervical spine will be used to calculate the degree
of canal compromise.
Interventions
Patients will be randomly allocated to undergo either
early surgery or delayed surgery.
Early surgery
Patients allocated to early surgery will undergo surgery
within 24 hours after admission. The time when they
enter the operating room will be used as a reference.
The principal goal of surgery is to achieve decompres-
sion of the spinal cord. The choice of anterior or poster-
ior approach will be left to the surgeon’s discretion. The
use of spinal instrumentation will be permitted when
needed. The surgery will be performed by or under
supervision of a board-certified orthopedic surgeon. The
details of the surgical treatment and any perioperative
adverse events will be recorded in a web-based prede-
fined form. All patients will receive intensive rehabilita-
tion tailored to the individual and injury-specific factors
immediately after surgery.
Delayed surgery
Patients allocated to the delayed surgery group will receive
conservative treatment consisting of early mobilization
and intensive rehabilitation for at least two weeks after the
injury. Surgical decompression will be performed by the
same team as in the early surgery group at any time later
than two weeks after the injury when the physician thinksthe timing is appropriate. Physicians will be allowed to
treat patients non-surgically as long as the patients can
achieve independent ambulation.
Other treatments
Apart from the surgical management, all patients will re-
ceive appropriate medical support, including permissive
or induced hypertensive therapy (mean blood pressure >
85 mmHg) [13]. High-dose methylprednisolone will be
used per the discretion of the treatment team according
to the NASCIS-2 protocol [1,14,15]. The use or lack of
high-dose methylprednisolone must be determined and
entered into the web-based database prior to the
randomization. Physicians will not be allowed to change
or discontinue the administration of methylprednisolone
after randomization.
Primary and secondary outcomes
Participants will be evaluated two weeks, three months,
six months and one year after randomization. Table 1
provides an overview of the outcomes that will be used
in this study. Physicians and research nurses who are
not involved in the patient’s care will assess the outcome
at each follow-up examination before the patients see
their doctors.
Primary outcomes
The primary outcome is a recovery in motor function
one year after injury. The assessment will include: 1) the
change from baseline to one year after the admission in
the ASIA motor score; 2) the total score of the Spinal
Cord Independence Measure (SCIM) version 3 and 3)
the proportion of patients who regained the ability to
walk 100 meters without human assistance.
The ASIA motor score is a 100-point score based on
ten pairs of key muscles, each given a five point rating.
The SCIM is a validated 100-point disability scale devel-
oped specifically for patients with SCI, with an emphasis
on daily tasks grouped into three subscales: self-care (20
points), respiration and sphincter management (40
points) and mobility (40 points) [16-18].
Secondary outcomes
The secondary outcomes will include: 1) the health-
related quality of life as measured by the Medical Out-
comes Study Short Form 36 (SF-36) [19,20] and the
EuroQol 5 Dimension (EQ-5D) [21]; 2) the neuropathic
pain at the injured level and below as assessed by the
Neuropathic Pain Symptom Inventory (NPSI) [22] and
3) the walking status as evaluated with the Walking
Index for Spinal Cord Injury (WISCI) II [23].
The scores on the SF-36 will be used as a generic meas-
ure of the patient health status. The SF-36 comprises eight





















Plain radiographs Xa X X
Neurological assessment
including the ASIA
motor score and ASIA
impairment scale
Xa X X X X
Evaluation of adverse events
SCIM version 3 X X X X
WISCI II X X
SF-36 X X
EQ-5D X X X X
NPSI X X
Xa: obtained prior to enrollment; ASIA: American Spinal Injury Association; EQ-
5D: EuroQol 5 Dimension; NPSI, Neuropathic Pain Symptom Inventory; SCIM:
Spinal Cord Independence Measure; SF-36: Medical Outcomes Study Short
Form 36; WISCI: Walking Index for Spinal Cord Injury.
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The NPSI is a self-questionnaire specifically designed
to evaluate the different symptoms of neuropathic pain.
It includes 12 items, each of which is quantified on a (0
to 10) numerical scale. The pain associated with SCI is
classified into two categories: at-level pain and below-
level pain. Participants will be asked to complete the
NPSI separately for pain in the upper extremities (at-
level pain) and in the trunk and lower extremities
(below-level pain). The WISCI II is a valid 21-level hier-
archical scale of walking based on physical assistance,
the need for braces and devices, with an ordinal range
from 0 (unable to walk) to 20 (walking without assist-
ance for at least 10 meters).
Adverse events
The occurrence of pre-specified adverse events will be
also assessed. Adverse events will be gathered from pa-
tients themselves and from the patient record review.
The a priori defined adverse events are: worsening of
paralysis in the upper extremities, worsening of paralysis
in the lower extremities, reoperation, use of a respirator
(more than one week), tracheostomy, sepsis, pneumonia,
acute respiratory distress syndrome, atelectasis, otherrespiratory complications, wound infection (superficial),
wound infection (deep), urinary tract infection, other in-
fections, gastrointestinal bleeding, peptic ulcer, ileus,
acute myocardial infarction, other cardiac events, pul-
monary embolism, cerebrovascular complication, liver
dysfunction/disease, renal dysfunction/disease, delirium,
depression, other complications and death.
Sample size
For this exploratory trial, the sample size was deter-
mined primarily based on feasibility. We assumed that it
is feasible to enroll approximately 100 patients (50 pa-
tients per group) during the planned study period. As
there is no valid data to indicate the optimal endpoint to
evaluate the neurological and functional recovery of SCI
patients, we selected three candidate endpoints as the
primary endpoint: 1) the change from the baseline to
one year after the admission in the ASIA motor score; 2)
the proportion of patients who regained the ability to
walk 100 meters without human assistance and 3) the
total score of the Spinal Cord Independence Measure
(SCIM) version 3.
We need 45 patients per group when the difference to
be detected in the ASIA motor score between the groups
is 12 points and the common standard deviation is 20.
Additionally, we expect that the percentage of ambula-
tory patients one year after the injury will increase from
50% to 80%. To detect this difference, we need 39 pa-
tients for each group. With regard to the SCIM, there
are few data that can be used as a basis for sample size
calculation. For the reasons above, we set the sample
size to be 50 patients per group. All calculations assume
an 80% power at a two-tailed significance level of 0.05.
Statistical methods
All analyses will be based on an intention-to-treat prin-
cipal, and will be performed with two-sided P-values
considered significant when they are below 0.05. For a
detailed analysis, the statistician will make a statistical
analysis plan before the data lock, as indicated below:
1) Primary endpoint:
 ASIA motor score
Calculate the difference one year after the
baseline, and compare the two groups using a
t-test
 The proportion of patients who regained the
ability to walk
Calculate the rate of patients who can walk one
year after the baseline, and compare the two
groups using the chi-square test
 SCIM
Compare the differences in the SCIM after one
year.
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Compare the differences in the WISCI II, SF-36
and EQ-5D. For the SF-36, we plan to use only the
total points, and not to compare each domain.
3) Safety:
We will compare the rates of adverse events
between the groups. In particular, in patients that
are moved out of the surgical standby group, we
will compare the ratio of the occurrence of
adverse events with those in the patients in the
early operation group.
Planned subgroup analyses
Predefined subgroup analyses will be performed in
patients with or without OPLL. These will include high-
dose methylprednisolone treatment, preexisting gait dis-
turbance and severe canal compromise (> 50% canal
compromise). Based on our previous study, we hypo-
thesize that early surgical decompression will be benefi-
cial in patients with preexisting gait disturbance and
those with severe canal compromise.
Ethical issues
The study protocol was approved by the local ethics
committees of all participating hospitals and will be
done in accordance with the Declaration of Helsinki.
The study will be overseen by an independent safety
monitoring board. All participants will give written in-
formed consent before entry.
Ethical approval was obtained from all participating
hospitals. The results will be disseminated via the usual
scientific forums, including peer-reviewed publications
and presentations at international conferences.
Discussion
Despite intensive basic and clinical research, an effect-
ive treatment for cervical SCI has not been established.
In the presence of preexisting canal stenosis, the role
of surgical decompression and its optimal timing con-
tinue to be subjects of intense debate. Addressing the
issue of the timing of surgical intervention is critical in
that, if the timing of surgery has no effect on the pa-
tient’s outcome, then all patients can initially be treated
non-surgically and surgery can be delayed for weeks or
even months after the injury without compromising
the patient’s recovery [6]. On the other hand, if early sur-
gical decompression is proven to be beneficial, drastic
changes in the medical service system, including logistics,
should be made to ensure that all SCI patients receive
early surgery.
In conducting clinical studies on SCI, the heterogen-
eity of the study population can be a major obstacle, es-
pecially in the acute phase. SCI patients vary greatly in
the severity of paralysis and neurological prognosis.Clinical studies including patients with various degrees
of neurological injury may have insufficient power.
Therefore, in this study, we will focus on patients with
ASIA C status. In a recent review, the consensus of ex-
perts was that it is reasonable to consider early surgical
decompression in patients with profound neurologic def-
icit (ASIA C) and spinal canal stenosis without fracture
or instability. On the other hand, those with a less severe
deficit (ASIA D) can be treated with initial observation
with surgery potentially performed at a later date [6].
We will exclude patients with ASIA B status, because
these patients are often difficult to distinguish from
ASIA A patients at the time of admission.
The information available regarding the window of op-
portunity or therapeutic window in human SCI is impre-
cise [24] and the definition of ‘early surgery’ has not yet
been well established. Although the ideal cutoff time at
which surgery provides potential neuroprotection is not
known, the most intensively investigated times in the
prior studies were 24 and 72 hours. In this study, we
have adopted a cutoff at twenty-two hours after admis-
sion mainly for practical and logistic reasons. Twenty-
four hours after admission is considered to be necessary
and sufficient to safely perform the initial evaluation of
patients and summon the operating team for emergency
surgery. In this study, we adopted the time of admission
as a reference, since the time of injury sometimes re-
mains conjectural.
The OSCIS study is designed to provide evidence of
the potential benefit of early surgical decompression
over a wait-and-see strategy. We believe that the results
of this trial will have a substantial impact on the man-
agement of cervical SCI.Trial status
The trial was registered in the UMIN register on 1 De-
cember, 2011. The first patient was randomized on 3 De-
cember, 2011. The trial is currently open for recruitment.Additional file
Additional file 1: List of participating hospitals with approval from
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